Blog
 » 
Infection
 » 
Resistant Staph Infections in Dogs (MRSA & MRSP Compared)

Resistant Staph Infections in Dogs (MRSA & MRSP Compared)

Infection

X min read

Owners

Understand resistant staph infections in dogs, how MRSA and MRSP differ, why resistance matters, and what it means for treatment decisions.

By 

Sustainable Vet Group

Updated on

August 13, 2026

.

This article is for informational purposes only and is not a substitute for professional veterinary advice. Every case is unique, so always consult your veterinarian for guidance specific to your pet.

This content is intended for veterinary professionals for educational purposes. It does not replace clinical judgment or tailored advice. Always rely on your training, expertise, and the specific context of your patients.

Resistant Staph Infections in Dogs (MRSA & MRSP Compared)

Two resistant staph strains affect dogs, and they are not the same organism, not equally common in dogs, and not managed identically. The distinction matters because the wrong treatment framework leads to incorrect assumptions about risk, prognosis, and management.

Here's a clear, direct comparison of what MRSA and MRSP are, how they differ, and what they mean for your dog.

 

Quick answer: MRSP (Methicillin-Resistant Staphylococcus pseudintermedius) is the dominant resistant staph strain in dogs: a dog-adapted organism that develops resistance through antibiotic pressure in canine populations. MRSA (Methicillin-Resistant Staphylococcus aureus) is primarily a human pathogen that dogs occasionally acquire from human contacts. MRSP is far more clinically significant in veterinary practice. Both require culture and sensitivity testing for diagnosis and guided treatment.

 

Key takeaways

  • MRSP is the dominant resistant staph in dogs: far more common than MRSA in canine infections.
  • MRSA is primarily a human pathogen: dogs acquire it from people, not from other dogs.
  • MRSP carries higher multidrug resistance than MRSA in dogs: 99% vs. 83% MDR per Belgian study data.
  • Both require culture and sensitivity testing for definitive diagnosis and treatment guidance.
  • MRSA in dogs does not carry greater mortality than susceptible S. aureus in dogs, per DVM360.
  • S. pseudintermedius is 35% prevalent in canine samples vs. 3.6% in feline samples per German 3-year study.

What they are: the biology

MRSP: the canine-adapted resistant staph

Staphylococcus pseudintermedius is a coagulase-positive staph species that colonizes approximately 50% of healthy dogs as normal skin flora. It causes most canine staph skin infections, ear infections, and post-surgical wound infections.

MRSP is the methicillin-resistant form. It acquires the mecA gene (usually via mobile genetic elements) that renders all beta-lactam antibiotics ineffective. Most MRSP isolates are also multidrug-resistant, carrying additional resistance to fluoroquinolones, clindamycin, tetracyclines, and aminoglycosides.

Origin of MRSP: S. pseudintermedius is a dog-adapted organism. MRSP develops within canine populations through antibiotic selection pressure: the dog's own bacteria become resistant through repeated antibiotic exposure.

MRSA: the human-origin resistant staph

Staphylococcus aureus is primarily a human pathogen that colonizes human nasal passages, skin, and mucous membranes. In humans, MRSA is a major cause of hospital-acquired and community-acquired infections.

In dogs, S. aureus colonization is substantially lower than S. pseudintermedius colonization. Today's Veterinary Practice confirms: "In dogs, prevalence of S. aureus colonization appears to be substantially lower than that of S. pseudintermedius. In addition, S. aureus infections are far less common than S. pseudintermedius infections."

Origin of MRSA in dogs: Dogs typically acquire MRSA from human contacts: household members carrying MRSA, veterinary staff, or hospital environments. MRSA in dogs is largely a human-to-dog transmission event.

Side-by-side comparison

FeatureMRSPMRSA
Full nameMethicillin-Resistant S. pseudintermediusMethicillin-Resistant S. aureus
Natural hostDogs (and cats)Humans
Prevalence in dogsCommon: dominant resistant staphUncommon: minority of resistant staph cases
Source in dogsDog's own bacteria (antibiotic pressure)Usually human-to-dog transmission
Multidrug resistance99% of canine isolates (Belgian study)83% of canine isolates (Belgian study)
Zoonotic riskLow but documentedModerate: well-documented human-dog transmission
Dog-to-dog spreadDocumented, especially with active lesionsUncommon (primarily human origin)
Treatment optionsLimited; culture-guided essentialLimited; culture-guided essential
Implant associationStrong (biofilm former)Less commonly implant-associated in dogs
Outcome vs. susceptible strainSimilar prognosis with correct treatmentSimilar prognosis, no higher mortality vs. MSSA

 

Prevalence: how common is each in dogs?

MRSP is the clinically dominant resistant staph in dogs. A German 3-year study analyzing 175,171 bacterial examination results found S. pseudintermedius in 44,880 samples (25.6% isolation rate), with methicillin resistance in 7.1% of canine isolates. This represents tens of thousands of MRSP cases annually in veterinary practice.

MRSA in dogs is comparatively rare. DVM360's analysis found that in dogs with inflamed skin, S. aureus was cultured in only 12% of cases, and of those, only 17% were methicillin-resistant. The overall MRSA contribution to canine resistant staph cases is small.

A Belgian 2025 study found 99% of canine MRSP isolates were multidrug-resistant organisms (MDROs), vs. 83.3% of MRSA isolates, confirming MRSP carries a broader resistance profile in dogs than MRSA does.

For MRSP specifically in context, see MRSP causes and symptoms. For non-resistant staph for comparison, see non-resistant staph for comparison.

Resistance patterns

Both organisms are resistant to all beta-lactam antibiotics by definition. Beyond that, resistance profiles differ.

MRSP multidrug resistance profile (typical canine isolates)

  • Clindamycin: 85.4% resistant (German study)
  • Trimethoprim-sulfa: 66.2% resistant (German study)
  • Fluoroquinolones, tetracyclines, aminoglycosides: frequently resistant
  • Potentially active agents (vary by isolate): chloramphenicol, rifampicin, potentiated sulfonamides, fusidic acid

MRSA resistance profile in dogs

  • Broad resistance to beta-lactams confirmed
  • Risk factors for MRSA include recent fluoroquinolone AND beta-lactam use (each raises risk independently)
  • Active agents: often similar to MRSP; guided by C&S results

Critical point for both: culture and sensitivity testing before antibiotic selection is mandatory. Empiric treatment of either MRSA or MRSP without sensitivity data risks treatment failure and further resistance selection.

For detailed antibiotic resistance mechanisms, see antibiotic resistance in MRSP infections.

Zoonotic risk: what human family members should know

Both organisms carry some zoonotic potential, but the risk profiles differ.

MRSP zoonotic risk:

  • Low overall transmission rate to healthy humans
  • Human infections documented in close-contact dog owners (published case series)
  • Immunocompromised humans face the highest risk
  • Hygiene precautions (handwashing, avoiding wound contact) are sufficient for most households

MRSA zoonotic risk:

  • Better documented than MRSP zoonosis
  • Bidirectional: humans transmit to dogs AND dogs can transmit back to humans
  • Particularly relevant in healthcare worker households (where MRSA is occupationally acquired)
  • More associated with human clinical infections than MRSP when zoonotic transmission occurs

For human transmission risk specifically, see detailed comparison of MRSA and MRSP.

Treatment: where MRSA and MRSP diverge

Both MRSA and MRSP require culture and sensitivity testing before antibiotic selection. Some practical differences:

Treatment aspectMRSPMRSA
Topical chlorhexidineHighly effective, first-lineEffective
ChloramphenicolOften active (North American MRSP)Sometimes active
RifampicinUse in combination onlyUse in combination only
DoxycyclineVariable (European clone more susceptible)Variable
LinezolidLast resort, infectious disease consultationLast resort
Hospital-grade antibioticsRequired for MDR casesRequired for MDR cases

 

For treatment options for resistant staph infections, see treatment options for resistant staph.

Frequently asked questions

My dog was diagnosed with resistant staph but the report doesn't say MRSA or MRSP. How do I find out which?

Speciation (identifying the exact Staphylococcus species) requires the laboratory to perform additional identification beyond generic "coagulase-positive Staphylococcus." Call the lab and ask them to speciate the isolate. Today's Veterinary Practice recommends: "If a coagulase-positive Staphylococcus species is identified but not speciated, call the laboratory to make sure this essential test is done."

Is MRSA in dogs more dangerous than MRSP?

Not inherently. DVM360 notes: "Unlike MRSA in people, which is often associated with increased morbidity and mortality, there does not appear to be a significant difference in patient outcome between dogs infected with MSSA versus MRSA." Both MRSA and MRSP in dogs carry broadly similar prognosis with correct, culture-guided treatment.

Can my dog give me MRSP if it has MRSA?

No: MRSA and MRSP are different species. A dog with MRSA cannot transmit MRSP to a human. The zoonotic concern with MRSA is transmission of S. aureus (the same species that causes MRSA in humans) between the dog and human household members.

MRSP and MRSA are both drug-resistant staph bacteria, but in dogs, they are not clinically equivalent. MRSP is the far more common, dog-adapted, and clinically challenging organism. MRSA in dogs is an occasional human-to-dog transmission event that carries lower canine prevalence and somewhat narrower multidrug resistance. Both require culture and sensitivity testing for diagnosis, and both respond to appropriate targeted therapy.

Resources

  • Today's Veterinary Practice. Methicillin-Resistant Staphylococcal Infections: Recent Developments. todaysveterinarypractice.com
  • DVM360. The emergence and prevalence of MRSA, MRSP, and MRSS in pets and people. dvm360.com
  • Ehricht et al. Comparative Analysis of MRSP Prevalence and Resistance Patterns in Canine and Feline Samples. PMC, 2024. ncbi.nlm.nih.gov
  • Depoorter et al. Antimicrobial Resistance of MRSA and MRSP Isolates from Clinical Cases in Dogs and Cats in Belgium. MDPI, 2025. mdpi.com

Get a Free Poster

Enhance your workspace with a high-quality radiographs reference poster, designed for veterinary professionals. This free physical poster will be shipped directly to you—just fill out the form to request your copy.

Things to know

Get a Free Poster for Your Clinic

Enhance your workspace with a high-quality radiographs reference poster, designed for veterinary professionals. This free physical poster will be shipped directly to you—just fill out the form to request your copy.

We'd love you to
Join Us!

Enter Your Details Below to Receive Your Information Pack

100% safe & secure. Your details are never shared or sold.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Taking Great TPLO Radiographs

Click Below to Watch Live Video Demos

We'll send you a Free Wall Poster with all the steps

Now that you are a pro at TPLO rads

Let's take your infection control to the next level

Watch these videos!

Step #1

Getting Ready

Ensuring a clean surgical field starts with proper skin preparation. This video demonstrates the best practices for:

  • Shaving the patient – Achieving a close, even shave while minimizing skin irritation
  • The Dirty Scrub – The initial skin prep step to remove surface debris and reduce bacterial load before the sterile scrub.

Following these techniques helps reduce infection risk and improve surgical outcomes. Watch the video to see how it’s done effectively!

Step #2

Reduce Your Risks

Many surgeons are shocked to find out that their patients are not protected from biofilms and resistant bacteria when they use saline and post-op antibiotics.

That’s Where Simini Comes In.

Why leave these risks and unmanaged?  Just apply Simini Protect Lavage for one minute. Biofilms and resistant bacteria can be removed, and you can reduce two significant sources of infection.

Step #3

Take the Course

Preventing surgical infections is critical for patient safety and successful outcomes. This course covers:

  • Aseptic techniques – Best practices to maintain a sterile field.
  • ​Skin prep & draping – Proper methods to minimize contamination.
  • ​Antibiotic stewardship – When and how to use perioperative antibiotics effectively.

Stay up to date with the latest evidence-based protocols. Click the link to start learning and earn CE credits!

Get Your
Free Poster!

Enter your information below, and we’ll ship it to you at no cost.

Do you want to customize it?

How many would you like?

About you

Shipping information

100% safe & secure. Your details are never shared or sold.

We will work on your request shortly.
Oops! Something went wrong while submitting the form.
What’s your role in animal care?

Tell us who you are so we can guide you to the most relevant information.